http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2141319-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14342fd58cd4377e2cc412f4431a3c12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate | 1997-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_921665328dda6930dae48512fad0c729 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06918cda06670381846c7b3a59e0233e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ed9cc7a7ebb6679b0a9c47cfcff7c09 |
| publicationDate | 1999-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2141319-C1 |
| titleOfInvention | Method of arresting abstinent syndrome in diseases associated with dependence on psychoactive substances |
| abstract | FIELD: medicine, narcology. SUBSTANCE: method involves administration of lidocaine hydrochloride 2% solution to patient with abstinent syndrome by intracutaneous route in cervical, paranephral and sacral region of the spine. Lidocaine is administrated at the dose 2 ml, 1-2 times per 24 h for 1-2 days. Course of treatment involves 2-6 procedures. EFFECT: decreased period of arresting, diminished intensity of abstinent disorders, simplified treatment. 2 cl, 2 ex |
| priorityDate | 1997-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.